(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 5. Manipulation of Shh levels. (A) Ectopic expression of Shh using Rcas-Shh.
(A1) Rcas-Shh/Fgf2-treated eyes show an increase in the expression of
Shh mRNA (arrowhead). (A2) Shh sense probe. (A3) Ectopic Shh
expression upregulates Ptc1 levels as indicated by the arrowhead.
(A4) Ptc1 sense probe. (A5) Ectopic Shh expression via a retroviral vector
corresponds to an increase in Shh protein (arrowheads). (A6) AMV3C2 staining
shows the presence of Rcas virus coat protein in Rcas-Shh-treated eyes
(arrowheads). (B) Real-time PCR analysis of the relative Ptc1 levels
in Fgf2, RCAS-Shh/Fgf2, and 100 µM KAAD/Fgf2-treated eyes show that
Rcas-Shh treatment causes and significant increase in Ptc1
(P<0.01) levels while KAAD/Fgf2 treatment reduces Ptc1
levels (P<0.05). * statistically significant. Error bars are
s.e.m.